CTLT DMA



As of date:11/1/2024
CTLT stock price:58.73
CTLT 50 DMA:60.03
CTLT 200 DMA:57.37
CTLT MACD (200-50):-2.66

Also see:
CTLT Market Cap History
CTLT Shares Outstanding History
CTLT YTD Return
CTLT RSI
CTLT MACD
CTLT Technical Analysis

Shares of EWZ Now Oversold
Friday, November 1, 9:39 PM


EDV Crowded With Sellers
Friday, November 1, 9:38 PM


Notable Two Hundred Day Moving Average Cross - IUSB
Friday, November 1, 9:38 PM


Notable Two Hundred Day Moving Average Cross - SAR
Friday, November 1, 9:38 PM


Notable Two Hundred Day Moving Average Cross - SUSC
Friday, November 1, 9:38 PM


iShares Broad USD Investment Grade Corporate Bond Breaks Below 200-Day Moving Average - Notable for USIG
Friday, November 1, 9:38 PM


SYLD Crosses Below Key Moving Average Level
Friday, November 1, 9:38 PM


Vanguard Intermediate-Term Corporate Bond (VCIT) Shares Cross Below 200 DMA
Friday, November 1, 9:38 PM


BBDC Crosses Below Key Moving Average Level
Friday, November 1, 9:38 PM


iShares MSCI Indonesia Getting Very Oversold
Friday, November 1, 9:38 PM


UTWO Makes Notable Cross Below Critical Moving Average
Friday, November 1, 9:36 PM


iShares iBonds Dec 2028 Term Treasury (IBTI) Shares Cross Below 200 DMA
Friday, November 1, 9:36 PM


Vanguard Total Corporate Bond Breaks Below 200-Day Moving Average - Notable for VTC
Friday, November 1, 9:36 PM


Notable Two Hundred Day Moving Average Cross - UBND
Friday, November 1, 9:36 PM


ZUMZ Makes Notable Cross Below Critical Moving Average
Friday, November 1, 9:32 PM


More Technical Analysis News

CTLT DMACTLT MACD
Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.

When researching a stock like Catalent, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from CTLT Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for CTLT stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the CTLT 200 day moving average ("CTLT 200 DMA"), while one of the most popular "shorter look-backs" is the CTLT 50 day moving average ("CTLT 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Catalent.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree CTLT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Catalent (CTLT) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

CVS DMA
DGX DMA
DHR DMA
DVA DMA
DXCM DMA
EW DMA
GEHC DMA
GILD DMA
HCA DMA
HOLX DMA
More Healthcare companies »

 

CTLT DMA | www.StockDMA.com | Copyright © 2019 - 2024, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.